Ginkgo honey ring (i.e., ginkgo honey ring oral solution) and 20mg rivaroxaban can generally be co-administered under the supervision of a physician, pay attention to the contraindications and adverse reactions. Ginkgo biloba oral solution can inhibit platelet aggregation, anti-thrombosis, etc. It is suitable for ischemic cerebrovascular disease, coronary heart disease, angina pectoris caused by heart and brain ischemic symptoms improvement. Contraindications and adverse reactions are not clear. Rivaroxaban has an anticoagulant effect and is indicated in adult patients undergoing elective hip and knee replacement surgery to prevent venous thrombosis, or for the treatment of deep vein thrombosis in adults to reduce the risk of recurrence and pulmonary embolism, or in adult patients with non-valvular atrial fibrillation with risk factors (e.g., age ≥75 years, diabetes mellitus, hypertension, etc.) to reduce the risk of stroke and systemic embolism. Contraindications to the use of the drug include hypersensitivity to the product, persons with clinically significant active bleeding, lesions or conditions with significant risk of major bleeding, patients with hepatic disease with coagulation abnormalities and clinically relevant risk of bleeding, and pregnant and lactating women, among other conditions. The most common adverse reaction following administration of the drug is bleeding. Ginkgo biloba oral solution and rivaroxaban (specification 20mg/tablet) generally do not have drug interactions and can be co-administered under physician supervision for anticoagulant and antiplatelet effects. Specific can follow the doctor’s instructions.